SemperVirens
SemperVirens

SemperVirens

DR34

Website
2018Venture Capital9 portfolioUnited States

About

SemperVirens is an early stage venture capital fund investing in technology transforming work, health, and financial wellness.

Key facts

At-a-glance profile data

Website
sempervirensvc.com
Type
Venture Capital
Headquarters
United States
Portfolio companies
9
Stages
Seed
Series A
Series B
Series D
Cheque size
$3M to $190M
Sector focus
Enterprise
Office Space
Workforce Management
Sales
Simulation

Recent investments

Recent funding rounds SemperVirens took part in
DateCompanyRoundAmount
29 May 2024Second NatureSeries B$22M
16 Apr 2024Take2 AISeed$3M
16 May 2023Laguna HealthSeries A$16M
28 Feb 2023GableSeries A$12M
Add first review

Frequently asked

What companies has SemperVirens invested in?

SemperVirens has invested in Second Nature, Take2 AI, Laguna Health, Gable, Mosey and 4 more.